The microtome market has seen considerable growth due to a variety of factors.
• In recent years, the microtome market has seen significant growth and is expected to expand from $0.24 billion in 2024 to $0.26 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%.
This past growth in the market can be credited to factors such as increased awareness of the importance of early diagnosis, a heightened demand for biopsies, a rising elderly population, growing demand for microtomes, and an increasing incidence of cancer.
The microtome market is expected to maintain its strong growth trajectory in upcoming years.
• In the forthcoming years, substantial growth is projected for the microtome market, with its value predicted to reach $0.34 billion in 2029, reflecting a compound annual growth rate (CAGR) of 6.5%.
The factors contributing to this market expansion during the forecast period include an increasing incidence of chronic illnesses, a larger elderly population, growing occurrence of oncological disorders, enhanced use of microtomes in neuroscience, and the advancement of precision medicine. In the same timeframe, key market trends are expected to encompass advancements in automation, programmable motorized microtomes, the emergence of diamond-coated blades, integration into imaging systems, and progress in high-resolution sectioning.
The increase in cases of oncological disorders is projected to spur the expansion of the microtome market in the future. Oncological disorders are diseases characterized by the uncontrolled growth and spread of abnormal cells, which often result in cancer. Several factors contribute to the growing prevalence of oncological disorders, namely an aging population, increased contact with environmental carcinogens, unhealthy lifestyles, and genetic predispositions. Microtomes aid pathologists by providing exact tissue sections for examination of cancer cells and identifying the tumor type and its progress. For example, the World Health Organization, an international public health institution based in Switzerland, reported in February 2024 that almost 20 million new cases of cancer were recorded in 2022, leading to about 10 million deaths. Forecasts indicate that annual cancer incidences could escalate to 35 million by 2050, signaling a 77% surge from 2022 numbers. Hence, the increasing occurrence of oncological disorders is fueling the expansion of the microtome market.
The microtome market covered in this report is segmented –
1) By Product: Instruments, Accessories
2) By Technology: Fully Automated, Semi-Automated, Manual
3) By Application: Disease Diagnosis, Medical Research
4) By End-User: Hospitals, Clinical And Diagnostic Laboratories, Academic Research Centers, Other End-Users
Subsegments:
1) By Instruments: Rotary Microtome, Cryostat Microtome, Vibrating Microtome, Ultramicrotome, Sledge Microtome
2) By Accessories: Blades And Knives, Blade Holders, Specimen Holders, Sectioning Aids, Safety Covers And Disposables
Leading corporations in the microtome market are emphasizing the development of cutting-edge products like tissue sectioning devices, aimed at enhancing laboratory efficiency and improving outcomes in both clinical and research settings. Tissue slicing devices are indispensable lab tools, providing consistent and accurate tissue sections for histology, research, and diagnostic applications. For instance, in February 2023, US-based Precisionary Instruments, a producer of microtomes, introduced a fresh range of rotary microtomes. The new line offers significant characteristics such as a heavy, stable core perfect for sequential sectioning, ensuring uniform outcomes with large sample sets. The RF-600 manual model encompasses double specimen clamp holders for multiple cassette sizes, while the RF-800 and RF-1000 models are equipped with LCD touchscreen controls. The RF-1000 model offers fully automatic cutting functionalities that can be operated via touchscreen, control panel, or foot pedal, thereby enhancing operational efficiency. These microtomes are specifically tailored for paraffin-embedded tissue sectioning in histology research.
Major companies operating in the microtome market are:
• Cardinal Health Inc.
• Leica Biosystems Nussloch GmbH
• Sakura Finetek Inc.
• RWD Life Science Co. Ltd.
• SM Scientific Instruments Pvt. Ltd.
• Narang Medical Limited
• AGD Biomedicals Pvt. Ltd.
• Diapath S.p.A.
• Milestone Medical
• Boeckeler Instruments Inc.
• SLEE Medical GmbH
• microTec Laborgeräte GmbH
• Campden Instruments
• Precisionary Instruments LLC
• Jinhua YIDI Medical Appliance Co. Ltd.
• Medimeas
• Histo-Line Laboratories
• MEDITE Medical GmbH
• Erma Inc.
• CellPath Ltd.
• Laboid International
North America was the largest region in the microtome market in 2024. The regions covered in the microtome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.